Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 2
1996 5
1997 1
1999 6
2000 3
2001 3
2002 2
2004 4
2005 2
2006 3
2007 4
2008 4
2009 2
2010 2
2011 2
2012 2
2013 2
2014 2
2015 2
2017 2
2018 2
2019 2
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16334127

61 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of metastatic neuroendocrine carcinomas based on WHO classification.
Artale S, Giannetta L, Cerea G, Maggioni D, Pedrazzoli P, Schiavetto I, Napolitano M, Veronese S, Bramerio E, Gambacorta M, Vanzulli A, Pisconti S, Pugliese R, Siena S. Artale S, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4463-9. Anticancer Res. 2005. PMID: 16334127 Free article.
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.
Hadoux J, Malka D, Planchard D, Scoazec JY, Caramella C, Guigay J, Boige V, Leboulleux S, Burtin P, Berdelou A, Loriot Y, Duvillard P, Chougnet CN, Déandréis D, Schlumberger M, Borget I, Ducreux M, Baudin E. Hadoux J, et al. Endocr Relat Cancer. 2015 Jun;22(3):289-98. doi: 10.1530/ERC-15-0075. Epub 2015 Mar 13. Endocr Relat Cancer. 2015. PMID: 25770151
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A, Carlini P, Ruggeri EM, Gamucci T, Pollera CF, De Marco S, Fariello AM, Moscetti L, Gelibter A, Adami E, Sperduti I, Cognetti F. Felici A, et al. Cancer Chemother Pharmacol. 2006 Jan;57(1):59-64. doi: 10.1007/s00280-005-0032-5. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001173 Clinical Trial.
61 results